Current smokers at the time of primary treatment for localized prostate cancer have a higher risk of negative outcomes, including biochemical recurrence (BCR), metastasis, and cancer-specific mortality, according to a new literature review and meta-analysis.
Smoking at Time of Treatment Worsens Prostate Cancer Outcomes
source: Cancer Network